SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1352458509104586v1
15/7/802    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Yeh, E.
Right arrow Articles by Ramanathan, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yeh, E.
Right arrow Articles by Ramanathan, M
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

research-article

Retinal nerve fiber thickness in inflammatory demyelinating diseases of childhood onset

EA Yeh

Pediatric Multiple Sclerosis Center, State University of New York at Buffalo, Buffalo, New York, USA; Departments of Neurology, State University of New York at Buffalo, Buffalo, New York, USA

B Weinstock-Guttman

Pediatric Multiple Sclerosis Center, State University of New York at Buffalo, Buffalo, New York, USA; Departments of Neurology, State University of New York at Buffalo, Buffalo, New York, USAbguttman{at}thejni.org

N Lincoff

Ross Eye Institute, State University of New York at Buffalo, Buffalo, New York, USA; Ophthalmology, State University of New York at Buffalo, Buffalo, New York, USA

J Reynolds

Ross Eye Institute, State University of New York at Buffalo, Buffalo, New York, USA; Ophthalmology, State University of New York at Buffalo, Buffalo, New York, USA

A Weinstock

Departments of Neurology, State University of New York at Buffalo, Buffalo, New York, USA

N Madurai

Pediatric Multiple Sclerosis Center, State University of New York at Buffalo, Buffalo, New York, USA

N Agarwal

Pediatric Multiple Sclerosis Center, State University of New York at Buffalo, Buffalo, New York, USA; Departments of Neurology, State University of New York at Buffalo, Buffalo, New York, USA

P Buch

Ross Eye Institute, State University of New York at Buffalo, Buffalo, New York, USA; Ophthalmology, State University of New York at Buffalo, Buffalo, New York, USA

M Karpinski

Pediatric Multiple Sclerosis Center, State University of New York at Buffalo, Buffalo, New York, USA; Departments of Neurology, State University of New York at Buffalo, Buffalo, New York, USA

M Ramanathan

Pediatric Multiple Sclerosis Center, State University of New York at Buffalo, Buffalo, New York, USA; Departments of Neurology, State University of New York at Buffalo, Buffalo, New York, USA; Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York, USA

Purpose

To evaluate retinal nerve fiber layer thickness (RNFLT) using optical coherence tomography (OCT) in children with acquired demyelinating diseases.

Methods

This is a cross-sectional study of patients seen between 2006–2008 at the Pediatric MS Center of the Jacobs Neurological Institute. Consensus definitions for pediatric demyelinating disease were followed. All children received OCT testing and assessment of visual acuity (VA) using Snellen and low contrast letter acuity (LCLA) charts.

Results

Thirty-eight children diagnosed with acquired demyelinating disease, 15 healthy controls, and five children with other neurological disorders (OND) were included. Average RNFLT in healthy controls was 107 ± 12 µm(n = 30) versus 108 ± 5 µm (n = 10) in OND controls. In children with multiple sclerosis, average RNFLT ± SD was 99 ± 14 µm in unaffected (n = 24) versus 83 ± 12 µmin eyes affected by optic neuritis ("affected eyes") (n = 10). Average RNFLT in children with acute disseminated encephalomyelitis and transverse myelitis was 102 ± 15 µm in unaffected (n = 18) versus 67 ± 17 µm in affected eyes (n = 6). In children with optic neuritis (ON), average RNFLT ± SD was 97 ± 13 µm in unaffected (n = 5) versus 89 ± 12 µm in affected eyes (n = 9). Differences between children with demyelinating disease and controls and between ON and nonON eyes were statistically significant (P < 0.001). Bivariate correlations of RNFLT with LCLA (P = 0.002) and VA (P < 0.001) were significant.

Conclusions

OCT may be a valuable tool for the assessment and monitoring of anterior optic pathway dysfunction in children with demyelinating diseases.

Key Words: acute disseminated encephalomyelitis • low contrast letter acuity • multiple sclerosis • optical coherence tomography

This version was published on July 1, 2009

Multiple Sclerosis, Vol. 15, No. 7, 802-810 (2009)
DOI: 10.1177/1352458509104586


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement